|
TAF1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.683980E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.232300E-02 |
| Normal-vs-Stage2 |
2.399400E-04 |
| Normal-vs-Stage3 |
2.397400E-03 |
| Normal-vs-Stage4 |
2.27809999999717E-05 |
| Stage1-vs-Stage2 |
1.419590E-02 |
| Stage1-vs-Stage3 |
5.862000E-02 |
| Stage1-vs-Stage4 |
1.242400E-03 |
| Stage2-vs-Stage3 |
2.982400E-01 |
| Stage2-vs-Stage4 |
9.446400E-01 |
| Stage3-vs-Stage4 |
1.925590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.636900E-03 |
| Normal-vs-AfricanAmerican |
8.086300E-02 |
| Normal-vs-Asian |
1.898750E-01 |
| Caucasian-vs-AfricanAmerican |
9.860000E-01 |
| Caucasian-vs-Asian |
3.867400E-01 |
| AfricanAmerican-vs-Asian |
5.761200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.584400E-04 |
| Normal-vs-Female |
8.544500E-03 |
| Male-vs-Female |
5.950400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.200960E-01 |
| Normal-vs-Age(41-60Yrs) |
1.562870E-03 |
| Normal-vs-Age(61-80Yrs) |
1.419040E-04 |
| Normal-vs-Age(81-100Yrs) |
2.008500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.374500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.557500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.367000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.452440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.698400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.576800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.098200E-02 |
| Classical-VS-Follicular |
2.62019999996976E-06 |
| Classical-VS-Other |
3.006600E-01 |
| Classical-VS-Normal |
1.714420E-01 |
| Tall-VS-Follicular |
1.291190E-01 |
| Tall-VS-Other |
7.958000E-01 |
| Tall-VS-Normal |
7.643600E-03 |
| Follicular-VS-Other |
6.306200E-01 |
| Follicular-VS-Normal |
1.68560000000095E-05 |
| Other-VS-Normal |
7.716000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.407920E-04 |
| Normal-vs-N1 |
1.016360E-02 |
| N0-vs-N1 |
8.297000E-01 |
|
|
